Futura Medical Share News (FUM)
FUM Share
FUM Share
FUM Share
FUM Share
FUM
FUM Share
FUM Level 2
FUM Live
FUM Broker
FUM Directors
FUM Financial
FUM
FUM Short
FUM
Last checked at -
(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of initial laboratory and optimisation work on a 'Dermasys' cannabidiol gel, dubbed 'CBD100', under the joint venture collaboration agreement with CBDerma Technology that was announced in September.
Read more
IN BRIEF: Futura Submits MED3000 Under EU Medical Device Regulation
Read moreFutura Medical Reports Limited Impact Of Covid-19 On Its Operations
Read more(Sharecast News) - Futura Medical updated the market on Wednesday, reporting that the impact of the Covid-19 pandemic on the company had been "limited" to date.
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK BROKER RATINGS SUMMARY: JPMorgan Raises Homeserve To Overweight
Read more(Sharecast News) - Futura Medical has filed for a further pre-submission meeting with the US Food and Drug Administration (FDA), it announced on Monday, following receipt of the complete and signed clinical study report for its phase 3 Study, 'FM57'.
Read moreFutura Files For Erectile Dysfunction Treatment Pre-Submission Meeting
Read moreFutura Optimistic Over Approvals For Erectile Dysfunction Treatment
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreFutura Pursues Regulatory Approval For Erectile Dysfunction Treatment
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreFutura Medical Raises GBP3.3 Million In Offer Backed By Lombard Odier
Read moreFutura Medical To Raise GBP3.3 Million In Shares After Test Failure
Read moreFutura Medical Erectile Dysfuction Drug MED2005 Fails To Beat Placebo
Read more
Last checked at